Skip to main content
. 2022 Mar 19;22:105. doi: 10.1186/s12883-022-02635-z

Table 2.

The pulmonary function parameters that significantly associated with survival after adjustment for possible influencing factorsa

pulmonary function parameter β SE Wald P* HR(95%CI)*
FVC
  > 86.42 1.000
 66.82–86.42 0.467 0.232 4.068 0.044 1.595(1.013,2.511)
  < 66.82 1.202 0.245 24.045  < 0.001 3.326(2.057,5.377)
FEV1
  > 90.74 1.000
 72.62–90.74 0.277 0.223 1.537 0.215 1.319(0.851,2.044)
  < 72.62 1.286 0.239 28.909  < 0.001 3.618(2.264,5.781)
PEF
  > 87.40 1.000
 63.18–87.40 0.679 0.230 8.696 0.003 1.971(1.256,3.094)
  < 63.18 1.339 0.259 26.828  < 0.001 3.816(2.299,6.334)
MEF75%
  > 91.02 1.000
 66.26–91.02 0.639 0.222 8.270 0.004 1.894(1.226,2.928)
  < 66.26 0.824 0.251 10.765 0.001 2.280(1.393,3.730)
MVV
  > 71.15 1.000
 42.41–71.15 0.925 0.230 16.164  < 0.001 2.522(1.607,3.959)
  < 42.41 1.460 0.251 33.780  < 0.001 4.308(2.632,7.049)

Abbreviation: HR Hazard Ratio, FVC Forced Vital Capacity, FEV1 Forced Expiratory Volume in 1 s, PEF Peak Expiratory Flow, MEF75% Maximal Expiratory Flow at 75% of FVC, MVV Maximal Voluntary Ventilation

a Possible influencing factors included sex, age of onset, site of onset, BMI, use of riluzole, acceptance of PEG, use of NIPPV, smoking, hypertension, diabetes mellitus, ALSFRS-R score at pulmonary function test, progression rate (ΔALSFRS-R), and time interval between disease onset and pulmonary function test

* Multivariate Cox survival analysis, Backward Stepwise (Wald)